Cargando…

A Risk Scoring System Utilizing Machine Learning Methods for Hepatotoxicity Prediction One Year After the Initiation of Tyrosine Kinase Inhibitors

BACKGROUND: There is currently no method to predict tyrosine kinase inhibitor (TKI) -induced hepatotoxicity. The purpose of this study was to propose a risk scoring system for hepatotoxicity induced within one year of TKI administration using machine learning methods. METHODS: This retrospective, mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Ji Min, Yee, Jeong, Cho, Soyeon, Kim, Min Kyoung, Moon, Jin Young, Jung, Dasom, Kim, Jung Sun, Gwak, Hye Sun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957909/ https://www.ncbi.nlm.nih.gov/pubmed/35350572 http://dx.doi.org/10.3389/fonc.2022.790343

Ejemplares similares

Machine Learning Approaches to Predict Hepatotoxicity Risk in Patients Receiving Nilotinib
por: Kim, Jung-Sun, et al.
Publicado: (2021)

Risk factors for erlotinib-induced hepatotoxicity: a retrospective follow-up study
por: Kim, Min Kyoung, et al.
Publicado: (2018)

Factors Influencing Imatinib-Induced Hepatotoxicity
por: Han, Ji Min, et al.
Publicado: (2020)

AXL and MET receptor tyrosine kinases are essential for lung cancer metastasis
por: Choi, Yun Jung, et al.
Publicado: (2019)

Risk Scoring System for Vancomycin-Associated Acute Kidney Injury
por: Kim, Jee Yun, et al.
Publicado: (2022)

Cross-Talk between Wnt Signaling and Src Tyrosine Kinase
por: Min, Jung Ki, et al.
Publicado: (2022)

Construction of a risk scoring system using clinical factors and RYR2 polymorphisms for bleeding complications in patients on direct oral anticoagulants
por: Jang, Eun Jeong, et al.
Publicado: (2023)

Gene Polymorphisms of the Renin-Angiotensin System and Bleeding Complications of Warfarin: Genetic-Based Machine Learning Models
por: Kim, Joo-Hee, et al.
Publicado: (2021)

Modulatory Effects of Silymarin on Benzo[a]pyrene-Induced Hepatotoxicity
por: Jee, Seung-Cheol, et al.
Publicado: (2020)

Tyrosine Kinase Inhibitor-Related Hepatotoxicity in Patients with Advanced Lung Adenocarcinoma: A Real-World Retrospective Study
por: Qian, Jie, et al.
Publicado: (2020)

Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors
por: Choi, Yun Jung, et al.
Publicado: (2013)

Machine Learning Approaches for Predicting Bisphosphonate-Related Osteonecrosis in Women with Osteoporosis Using VEGFA Gene Polymorphisms
por: Kim, Jin-Woo, et al.
Publicado: (2021)

Targeting CD73 to Overcomes Resistance to First-Generation EGFR Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer
por: Kim, Miso, et al.
Publicado: (2023)

Effects of CYP3A4*22 polymorphism on trough concentration of tacrolimus in kidney transplantation: a systematic review and meta-analysis
por: Kim, Jung Sun, et al.
Publicado: (2023)

Baseline Tyrosine Level Is Associated with Dynamic Changes in FAST Score in NAFLD Patients under Lifestyle Modification
por: Kim, Hwi Young, et al.
Publicado: (2023)

Establishment and characterization of patient-derived xenograft models of gastrointestinal stromal tumor resistant to standard tyrosine kinase inhibitors
por: Na, Young-Soon, et al.
Publicado: (2017)

Correction: Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors
por: Choi, Yun Jung, et al.
Publicado: (2019)

Interactive Associations between PPARγ and PPARGC1A and Bisphosphonate-Related Osteonecrosis of the Jaw in Patients with Osteoporosis
por: Kim, Jung Sun, et al.
Publicado: (2023)

Utility of the Z-score of log-transformed A Body Shape Index (LBSIZ) in the assessment for sarcopenic obesity and cardiovascular disease risk in the United States
por: Chung, Wankyo, et al.
Publicado: (2019)

A Receptor Tyrosine Kinase Inhibitor, Dovitinib (TKI-258), Enhances BMP-2-Induced Osteoblast Differentiation In Vitro
por: Lee, Yura, et al.
Publicado: (2016)

Korean version of the Cough Symptom Score: clinical utility and validity for chronic cough
por: Kwon, Jae-Woo, et al.
Publicado: (2017)

Multiple receptor tyrosine kinase activation related to ALK inhibitor resistance in lung cancer cells with ALK rearrangement
por: Choi, Se Hoon, et al.
Publicado: (2017)

Effects of White Radish (Raphanus sativus) Enzyme Extract on Hepatotoxicity
por: Lee, Sang Wha, et al.
Publicado: (2012)

Distinct Characteristics and Clinical Outcomes to Predict the Emergence of MET Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
por: Ahn, Beung-Chul, et al.
Publicado: (2021)

Targeted sequencing identifies genetic alterations that confer primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium)
por: Lim, Sun Min, et al.
Publicado: (2016)

Mechanisms of acquired resistance to EGFR-tyrosine kinase inhibitor in Korean patients with lung cancer
por: Ji, Wonjun, et al.
Publicado: (2013)

Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancer
por: Jung, Sangyong, et al.
Publicado: (2021)

Risk Scoring System of Mortality and Prediction Model of Hospital Stay for Critically Ill Patients Receiving Parenteral Nutrition
por: Kim, Jee-Yun, et al.
Publicado: (2021)

Synergistic induction of cancer cell migration regulated by Gβγ and phosphatidylinositol 3-kinase
por: Kim, Eun Kyoung, et al.
Publicado: (2012)

Concurrent Autophagy Inhibition Overcomes the Resistance of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Human Bladder Cancer Cells
por: Kang, Minyong, et al.
Publicado: (2017)

Neuroendocrine Differentiation in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
por: Chang, Youjin, et al.
Publicado: (2013)

Early monitoring for detection of antituberculous drug-induced hepatotoxicity
por: Lee, Chang Min, et al.
Publicado: (2016)

Statins Enhance the Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase Inhibitors
por: Jang, Hyeok-Jae, et al.
Publicado: (2021)

Lipid Profiles in Primary Aldosteronism Compared with Essential Hypertension: Propensity-Score Matching Study
por: Moon, Sun Joon, et al.
Publicado: (2021)

Metabolomics and Network Analyses Reveal Phenylalanine and Tyrosine as Signatures of Anthracycline-Induced Hepatotoxicity
por: Liu, Peipei, et al.
Publicado: (2023)

Ultrasonographic scoring system score versus liver stiffness measurement in prediction of cirrhosis
por: Moon, Kyoung Min, et al.
Publicado: (2013)

Reversing multidrug resistance by tyrosine kinase inhibitors
por: He, Miao, et al.
Publicado: (2012)

Prediction of medication-related osteonecrosis of the jaws using machine learning methods from estrogen receptor 1 polymorphisms and clinical information
por: Choi, Seo-Yong, et al.
Publicado: (2023)

The association between NAT2 acetylator status and adverse drug reactions of sulfasalazine: a systematic review and meta-analysis
por: Yee, Jeong, et al.
Publicado: (2020)

Patient-Initiated Discontinuation of Tyrosine Kinase Inhibitor for Chronic Myeloid Leukemia
por: Langabeer, Stephen E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7agq6hlkq2a4vug4unvls69ra3